Previously we reported that other histamine H3 receptor antagonist—KSK-19—not only prevented weight gain in a mouse model of obesity, but also significantly improved glucose tolerance and insulin resistance [10]. Here, HRH3 is linked to obesity due to melanocortin 4 receptor deficiency.